- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07645664
Scar Management Through Serial Casting
9. juni 2026 opdateret af: Bernadette Nedelec, Centre hospitalier de l'Université de Montréal (CHUM)
Scar management remains one of the major clinical challenges for burn survivors with hypertrophic scars.
Beyond their visible appearance, hypertrophic scars can significantly impair physical function, reduce life satisfaction, and affect overall quality of life.
According to the results of a recently completed study, the application of serial casts appears promising for the treatment of hypertrophic scars in adults who have survived a burn injury.
However, this therapeutic approach has not yet been evaluated objectively in terms of scar characteristics within the context of a study with sufficient statistical power.
The present project is the first study with sufficient statistical power to objectively evaluate the beneficial effects of serial casting on the characteristics of hypertrophic scars in adult burn survivors.
The objective of this study is to characterize changes in thickness, elasticity, vascularization, transepidermal water loss (TEWL), itching, and pain in hypertrophic burn scars in adults after one week of treatment with serial dressings, compared to an intra-individual control scar.
Our hypothesis is that relative to baseline measures the scar thickness (primary outcome), erythema index, TEWL, itch, and pain will decrease at treatment sites compared to control sites.
Conversely, elasticity will increase at the treatment sites compared to control sites.
This will be a prospective, longitudinal, evaluator-blinded, randomized intra-individual controlled trial.
Studieoversigt
Status
Ikke rekrutterer endnu
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
This will be a prospective, longitudinal, evaluator-blinded, randomized intra-individual controlled trial.
Participants will start serial casting on selected scars during 7 days for 24 hrs/day.
The objective scar characteristics and the subjective scar quality appreciation level will be evaluated immediately before and immediately after serial casting, and then 3 weeks after the cast has been removed.
Undersøgelsestype
Interventionel
Tilmelding (Anslået)
38
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiekontakt
- Navn: Jakub Sawicki, MSc
- Telefonnummer: 4229 514-288-8201
- E-mail: jakub.sawicki.chum@ssss.gouv.qc.ca
Undersøgelse Kontakt Backup
- Navn: Geneviève Schneider, MSc, OT
- Telefonnummer: 514-288-8201
- E-mail: genevieve.schneider.vmed@ssss.gouv.qc.ca
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
- Barn
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Ingen
Beskrivelse
Inclusion Criteria:
- adult burn survivors who have two scars that meet the diagnostic criteria of a HSc (erythema index greater than 300 and thickness greater than 2.034 mm) and with no more than 0.5 mm thickness difference between each other;
- are proficient in English and/or French;
- provide informed consent.
Exclusion Criteria:
- patients who sustained electrical or cold injury;
- formed keloid scars or have only mature scars (erythema index less than 300);
- have a a dermatological condition that could interfere with measurement reliability (eczema, psoriasis);
- have a cognitive/psychiatric condition that could impaired understanding of the consent process or adherence to protocol procedures.
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Enkelt gruppeopgave
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Treated scar
Serial casting treatment
|
At the preselected treatment site, a serial cast will be applied by a trained OT and worn by participant for 7 days.
|
|
Ingen indgriben: Control scar
No intervention, standard of care only.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Skin Thickness Changes
Tidsramme: right before intervention, right after intervention, three weeks after intervention
|
Ultrasound skin thickness (mm) measured by Dermascan
|
right before intervention, right after intervention, three weeks after intervention
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Subjective Scar Satisfaction Level
Tidsramme: right before intervention, right after intervention, three weeks after intervention
|
Subjective Scar Satisfaction Level evaluated by POSAS (Patient and Observer Scar Assessment Scale) v. 2.0 modified; visual analog scale (score 0-identical to- 10-very different from normal skin).
|
right before intervention, right after intervention, three weeks after intervention
|
|
Skin Erythema Changes
Tidsramme: right before intervention, right after intervention, three weeks after intervention
|
Erythema index measure by Mexameter, values from 0 to 999.
The erythema values are individual for each person and depend strongly on the skin type.
The measurements are generally used to determine changes before and after a treatment.
|
right before intervention, right after intervention, three weeks after intervention
|
|
Trans-epidermal water loss (TEWL)
Tidsramme: right before intervention, right after intervention, three weeks after intervention
|
Trans-epidermal water loss (TEWL) measured by Tewameter.
|
right before intervention, right after intervention, three weeks after intervention
|
|
Skin Melanin Changes
Tidsramme: right before intervention, right after intervention, three weeks after intervention
|
Melanin index measured by Mexameter
|
right before intervention, right after intervention, three weeks after intervention
|
|
Skin Elasticity Changes
Tidsramme: right before intervention, right after intervention, three weeks after intervention
|
Skin elasticity measures (mm) measured by Cutometer (r0)
|
right before intervention, right after intervention, three weeks after intervention
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: Bernadette Nedelec, PhD, OT(c), Centre Hospitalier de l'Universite de Montreal (CHUM)
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Anslået)
1. juni 2026
Primær færdiggørelse (Anslået)
1. november 2028
Studieafslutning (Anslået)
1. november 2028
Datoer for studieregistrering
Først indsendt
9. juni 2026
Først indsendt, der opfyldte QC-kriterier
9. juni 2026
Først opslået (Faktiske)
12. juni 2026
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
12. juni 2026
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
9. juni 2026
Sidst verificeret
1. juni 2026
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 2027-13669
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
INGEN
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Brænd ar
-
Cairo UniversityAfsluttetForbrændinger | Hypertrofisk ar | Burn Scar (Post-Burn)Egypten
-
Sohag UniversityAfsluttetCS Scar GraviditetEgypten
-
King Edward Medical UniversityTilmelding efter invitationPost Burn HyperpigmentationPakistan
-
Kringle Pharma, Inc.Rekruttering
-
Taipei Medical University WanFang HospitalAfsluttetOmtransplantation af huden; Donorsted for hudtransplantation; Vancouver Scar ScaleTaiwan
-
Cairo UniversityIkke rekrutterer endnuBurn i underekstremiteten | Funktion i underekstremitetenEgypten
-
Cairo UniversityRekruttering
-
VA Office of Research and DevelopmentIkke rekrutterer endnu
-
Central Arkansas Veterans Healthcare SystemUnited States Department of Defense; University of ArkansasRekrutteringÅbn Burn Pit ExposureForenede Stater
-
Nepal Health Research CouncilFogarty International Center of the National Institute of HealthRekruttering
Kliniske forsøg med Serial casted scar
-
Synochi, LLCLAC+USC Medical CenterIkke rekrutterer endnu
-
Antalya Training and Research HospitalIkke rekrutterer endnu
-
Florida State UniversityAfsluttetSmerte | Muskuloskeletale smerter | Kronisk smerteForenede Stater
-
Jessa HospitalAfsluttetAr | Minimalt invasiv hjertekirurgiBelgien
-
Region SkaneAfsluttetInfektion på det kirurgiske sted | PatienttilfredshedSverige
-
University of FloridaAfsluttet
-
University Hospital, GhentAfsluttetArvæv eller sund hudBelgien
-
Herbarium Laboratorio Botanico LtdaRekrutteringSikkerhed og effektivitet | Hypertrofiske ar | Keloid ar | Aktuel administration | Acceptabilitetsundersøgelse | Betingelser for reel brugBrasilien
-
Chinese University of Hong KongThe Hong Kong Polytechnic UniversityAfsluttetKnæarthropati | Hypertrofisk ar | HofteartropatiHong Kong
-
The Hong Kong Polytechnic UniversityAfsluttetRehabilitering | Cicatrix, hypertrofisk